loading...| Preferred Name |
Levocarnitine |
|
| Synonyms |
levocarnitine L-carnitine LEVOCARNITINE Levocarnitine Carnitor |
|
| Definitions |
An amino acid derivative. Levocarnitine facilitates long-chain fatty acid entry into mitochondria, delivering substrate for oxidation and subsequent energy production. Fatty acids are utilized as an energy substrate in all tissues except the brain. (NCI04) |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C26657 |
|
| Accepted_Therapeutic_Use_For |
Carnitine deficiency; End-stage renal disease |
|
| ALT_DEFINITION |
A form of carnitine, which is a substance made in muscle and liver tissue and found in certain foods, such as meat, poultry, fish, and some dairy products. Carnitor is also a drug that is used to treat patients who do not make enough carnitine and is being studied as a way to prevent tissue damage caused by chemotherapy. Carnitine is a type of dietary supplement. |
|
| CAS_Registry |
541-15-1 |
|
| CHEBI_ID |
CHEBI:16347 |
|
| Chemical_Formula |
C7H15NO3 |
|
| code |
C26657 |
|
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 |
|
| Contributing_Source |
CTRP FDA |
|
| DEFINITION |
An amino acid derivative. Levocarnitine facilitates long-chain fatty acid entry into mitochondria, delivering substrate for oxidation and subsequent energy production. Fatty acids are utilized as an energy substrate in all tissues except the brain. (NCI04) |
|
| Display_Name |
Levocarnitine |
|
| FDA_UNII_Code |
0G389FZZ9M |
|
| FULL_SYN |
levocarnitine L-carnitine LEVOCARNITINE Levocarnitine Carnitor |
|
| Has_Salt_Form | ||
| label |
Levocarnitine |
|
| Legacy Concept Name |
Levocarnitine |
|
| NCI_Drug_Dictionary_ID |
301896 |
|
| PDQ_Closed_Trial_Search_ID |
301896 |
|
| PDQ_Open_Trial_Search_ID |
301896 |
|
| Preferred_Name |
Levocarnitine |
|
| prefixIRI |
Thesaurus:C26657 |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0087163 |
|
| subClassOf |